Adverse reactions to contrast media: An analysis from spontaneous reporting data

Pharmacological Research

Volumn 56, Issue 1, 2007, Pages 35-41

  Cutroneo, Paola ^a   Polimeni, Giovanni ^a,b   Curcuruto, Roberto ^a   Calapai, Gioacchino ^a   Caputi, Achille P ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Adverse reactions; Contrast media; Spontaneous reporting

Indexed keywords

AMLODIPINE; BARIUM SULFATE; CONTRAST MEDIUM; DOXAZOSIN; GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOTERIC ACID; IOBITRIDOL; IODAMIDE; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; IOVERSOL;

ADULT; AGE DISTRIBUTION; AGED; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; COMA; CONTROLLED STUDY; CONVULSION; COUGHING; CYANOSIS; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; DYSPNEA; ERYTHEMA; FACE EDEMA; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTENSION; HYPOVOLEMIC SHOCK; LARYNX EDEMA; LUNG DISEASE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NAUSEA; PAPULAR RASH; POSTMARKETING SURVEILLANCE; PREVALENCE; PRIORITY JOURNAL; RASH; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SEX DIFFERENCE; SIDE EFFECT; SKIN ALLERGY; SKIN DISEASE; SNEEZING; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE; URTICARIA; VESICULAR RASH; VISUAL DISORDER; VOMITING; XEROSTOMIA;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; CONTRAST MEDIA; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IOHEXOL; IOPAMIDOL; MALE; MIDDLE AGED; SICILY;

EID: 34250875877     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.03.003     Document Type: Article

References (33)

1. Christiansen C. X-Ray contrast media-an overview. Toxicology 206 (2005) 185-187
2. Idèe J.M., Pinès E., and Philippe P. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 19 (2005) 263-281
3. GE Healthcare "Dear Healthcare Professional". June 2006. Available from URL: http://www.fda.gov/medwatch/safety/2006/gadolinium_NFD-NSF_dhcp.pdf.
4. Bristol-Myers Squibb Company "Dear Healthcare Professional". September 1996. Available from URL: http://www.fda.gov/medwatch/safety/1996/gluco.htm.
5. Naranjo C.A., Busto U., Sellers E.M., Sandor P., Ruiz I., Roberts E.A., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
6. Olsson S. Role of WHO programme on international drug monitoring in co-ordinating world-wide drug safety efforts. Drug Safety 19 (1998) 1-10
7. International Conference on Harmonization; E2D: Post-Approval safety data management: Definitions and standards for expedited reporting. May 2004 Available from URL http://www.emea.eu.int/pdfs/human/ich/394503en.pdf.
8. Brockow K., and and the EAACI interest group on drug hypersensitivity. Management of hypersensitivity reactions to iodinated contrast media. Allergy 60 (2005) 150-158
9. Ring J., and Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and Pathophysiology. Clin Rev Allergy Immunol 17 (1999) 387-399
10. Thomsen H.S., and Morcos S.K. Radiographic contrast media. BJU Int 86 (2000) 1-10
11. Spring D.B., Bettmann M.A., and Barkan H.E. Nonfatal adverse reactions to iodinated contrast media: spontaneous reporting to the U.S. Food and Drug Administration, 1978-1994. Radiology 204 (1997) 325-332
12. Meth M.J., and Maibach H.I. Current understanding of contrast media reactions and implications for clinical management. Drug Safety 29 (2006) 133-141
13. Spring D.B., Bettmann M.A., and Barkan H.E. Deaths related to iodinated contrast media reported spontaneously to the U.S. Food and drug Administration, 1978-1994: effect of the availability of low-osmolality contrast media. Radiology 204 (1997) 333-337
14. Namasivayam S., Kalra M.K., Torres W.S., and Small W.C. Adverse reactions to intravenous iodinated contrast media: an update. Curr Probl Diagn Radiol 35 (2006) 164-169
15. Runge V.M. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 12 (2000) 205-213
16. Meuli R.A., and Maeder P. Life-threatening anaphylactoid reaction after IV injection of gadoterate meglumine. Am J Roentg 166 (1996) 729
17. ®). Allerg Immunol (Paris) 35 (2003) 382-385
18. Bourrinet P., Martel E., El Amrani A.I., Champeroux P., Richard S., Fauchou N., et al. Cardiovascular safety of gadoterate meglumine (Gd-DOTA). Invest Radiol 42 (2007) 63-77
19. Herborn C.U., Honold E., Wolf M., Kemper J., Kinner S., Adam G., et al. Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol 42 (2007) 58-62
20. Esplugas E., Cequier A., Gomez-Hospital J.A., Del Blanco B.G., and Jara F. Comparative tolerability of contrast media used for coronary interventions. Drug Safety 25 (2002) 1079-1098
21. McClean B.L. Ionic and non-ionic iodinated contrast media: Evolution and strategies for use. AJR Am J Roentgenol 155 (1990) 225-233
22. Halpern J.D., Hopper K.D., Arredondo M.G., et al. Patient allergies: role in selective use of non-ionic contrast material. Radiology 199 (1996) 359-362
23. Enright T., Chua-Lim A., Duda E., et al. The role of a documented allergic profile as a risk factor for radiographic contrast media reaction. Ann Allergy 62 (1989) 302-305
24. Laroche D., Vergnaud M.C., Lefrancois C., Hue S., and Bricard H. Anaphylactoid reactions to iodinated contrast media. Acad Radiol 9 (2002) S431-S432
25. Leone R., Conforti A., Venegoni M., Motola D., Moretti U., Meneghelli I., et al. Drug-induced anaphylaxis. Drug Safety 28 (2005) 547-556
26. Neugut A.I., Ghatak A.T., and Miller R.L. Anaphylaxis in the United States: an investigation into epidemiology. Arch Intern Med 161 (2001) 15-21
27. Matasar M.J., and Neugut A.I. Epidemiology of anaphylaxis in the United States. Curr Allergy Asthma Rep 3 (2003) 30-35
28. Bettman M.A., Heeren T., Greenfield A., et al. Adverse events with radiographic contrast agents: results of the SCVIR contrast agent registry. Radiology 203 (1997) 611-620
29. Katayama H., Yamaguchi K., Kozuka T., et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175 (1990) 621-628
30. Laude E.A., Emery C.J., and Morcos S.K. Ventilatory effects of radiographic contrast media. Br J Radiol 71 (1998) 1143-1148
31. Dawson P., Pitfield J., and Britain J. Contrast media and bronchospasm: a study with iopamidol. Clin Radiol 34 (1983) 227-230
32. Bordet R., Gautier S., Le Louet H., Dupuis B., and Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 56 (2001) 935-941
33. Berlex, Inc. "Dear Healthcare Professional". July 2006. Available from URL: http://www.fda.gov/oc/po/firmrecalls/berlex207_06.html.